{"id":"https://openalex.org/W4319035162","doi":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","title":"ANALISIS BIAYA DAN KUALITAS HIDUP PASIEN RAWAT JALAN DM TIPE 2 DENGAN TERAPI GLIQUIDONE DIBANDINGKAN GLIMEPIRIDE DI RSUD SURAKARTA TAHUN 2021","display_name":"ANALISIS BIAYA DAN KUALITAS HIDUP PASIEN RAWAT JALAN DM TIPE 2 DENGAN TERAPI GLIQUIDONE DIBANDINGKAN GLIMEPIRIDE DI RSUD SURAKARTA TAHUN 2021","publication_year":2023,"publication_date":"2023-01-31","ids":{"openalex":"https://openalex.org/W4319035162","doi":"https://doi.org/10.24843/jfu.2022.v11.i02.p03"},"language":"id","primary_location":{"id":"doi:10.24843/jfu.2022.v11.i02.p03","doi":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","is_oa":true,"landing_page_url":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","pdf_url":"https://ojs.unud.ac.id/index.php/jfu/article/download/82775/48309","source":{"id":"https://openalex.org/S4210235517","display_name":"Jurnal Farmasi Udayana","issn_l":"2301-7716","issn":["2301-7716","2622-4607"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314998","host_organization_name":"Udayana University","host_organization_lineage":["https://openalex.org/P4310314998"],"host_organization_lineage_names":["Udayana University"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jurnal Farmasi Udayana","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ojs.unud.ac.id/index.php/jfu/article/download/82775/48309","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091040056","display_name":"Inaratul Rizkhy Hanifah","orcid":"https://orcid.org/0000-0003-1699-9173","observed_orcids":["https://orcid.org/0000-0003-1699-9173"]},"institutions":[{"id":"https://openalex.org/I4210130532","display_name":"Universitas Setia Budi","ror":"https://ror.org/03gn53446","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210130532"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Inaratul Rizkhy Hanifah","raw_affiliation_strings":["Universitas Setia Budi","Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta, 57127"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitas Setia Budi","institution_ids":["https://openalex.org/I4210130532"]},{"raw_affiliation_string":"Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta, 57127","institution_ids":["https://openalex.org/I4210130532"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079156984","display_name":"Ela Dewi Puspita Sari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130532","display_name":"Universitas Setia Budi","ror":"https://ror.org/03gn53446","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210130532"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Ela Dewi Puspita Sari","raw_affiliation_strings":["Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta","Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta, 57127"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta","institution_ids":["https://openalex.org/I4210130532"]},{"raw_affiliation_string":"Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta, 57127","institution_ids":["https://openalex.org/I4210130532"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006153286","display_name":"Samuel Budi Harsono","orcid":"https://orcid.org/0009-0004-8989-1619","observed_orcids":["https://orcid.org/0009-0004-8989-1619"]},"institutions":[{"id":"https://openalex.org/I4210130532","display_name":"Universitas Setia Budi","ror":"https://ror.org/03gn53446","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210130532"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Samuel Budi Harsono","raw_affiliation_strings":["Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta","Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta, 57127"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta","institution_ids":["https://openalex.org/I4210130532"]},{"raw_affiliation_string":"Program Studi S1 Farmasi, Universitas Setia Budi, Surakarta, 57127","institution_ids":["https://openalex.org/I4210130532"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210130532"],"apc_list":null,"apc_paid":null,"fwci":0.3477,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.6190519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"49","last_page":"49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.1534000039100647,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.996999979019165},{"id":"https://openalex.org/keywords/gliquidone","display_name":"gliquidone","score":0.9169999957084656},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9940000176429749},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.7710000276565552},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6000000238418579},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.8029999732971191},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.7900000214576721},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.663334846496582},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.6220347285270691}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.24843/jfu.2022.v11.i02.p03","doi":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","is_oa":true,"landing_page_url":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","pdf_url":"https://ojs.unud.ac.id/index.php/jfu/article/download/82775/48309","source":{"id":"https://openalex.org/S4210235517","display_name":"Jurnal Farmasi Udayana","issn_l":"2301-7716","issn":["2301-7716","2622-4607"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314998","host_organization_name":"Udayana University","host_organization_lineage":["https://openalex.org/P4310314998"],"host_organization_lineage_names":["Udayana University"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jurnal Farmasi Udayana","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.24843/jfu.2022.v11.i02.p03","doi":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","is_oa":true,"landing_page_url":"https://doi.org/10.24843/jfu.2022.v11.i02.p03","pdf_url":"https://ojs.unud.ac.id/index.php/jfu/article/download/82775/48309","source":{"id":"https://openalex.org/S4210235517","display_name":"Jurnal Farmasi Udayana","issn_l":"2301-7716","issn":["2301-7716","2622-4607"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314998","host_organization_name":"Udayana University","host_organization_lineage":["https://openalex.org/P4310314998"],"host_organization_lineage_names":["Udayana University"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jurnal Farmasi Udayana","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4319035162.pdf","grobid_xml":"https://content.openalex.org/works/W4319035162.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2337453253","https://openalex.org/W2529114377","https://openalex.org/W2612110100","https://openalex.org/W2948730742","https://openalex.org/W3158523259","https://openalex.org/W3217389362","https://openalex.org/W6629965658"],"related_works":["https://openalex.org/W7213534890","https://openalex.org/W3042434024","https://openalex.org/W4385265849","https://openalex.org/W7007984521","https://openalex.org/W330682354","https://openalex.org/W4285360165","https://openalex.org/W1576233483","https://openalex.org/W4406290922","https://openalex.org/W4319988756","https://openalex.org/W7219945992"],"abstract_inverted_index":{"Penyakit":[0],"Diabetes":[1,192],"Melitus":[2],"tipe":[3,61],"2":[4,62],"merupakan":[5],"penyakit":[6],"degeneratif":[7],"yang":[8,30,90,114,170,176],"diderita":[9],"oleh":[10],"pasien":[11,33,59,89],"seumur":[12],"hidup.":[13],"WHO":[14],"memperkirakan":[15],"jumlah":[16],"penderita":[17],"diabetes":[18],"di":[19,65],"Indonesia":[20],"sekitar":[21],"21,3":[22],"juta":[23],"pada":[24,32,36,68,121],"tahun":[25,69],"2030.":[26],"Pengontrolan":[27],"gula":[28],"darah":[29],"buruk":[31],"DM":[34,60],"berdampak":[35],"penurunan":[37],"kualitas":[38,57],"hidup":[39,58,135,195],"dan":[40,56,102,131],"peningkatan":[41],"biaya":[42,50,95,100,126,129,132,164],"kesehatan.":[43],"Tujuan":[44],"penelitian":[45,81,137],"ini":[46,82,119,138],"adalah":[47],"untuk":[48,111],"menganalisis":[49],"terapi":[51,113],"gliquidone":[52,147],"dibandingkan":[53,184],"dengan":[54,73,88,97,107,185],"glimepiride":[55,154],"rawat":[63],"jalan":[64],"RSUD":[66],"Surakarta":[67],"2021.":[70,124],"Penelitian":[71,118],"dilakukan":[72,96,120],"menggunakan":[74,140],"desain":[75],"studi":[76],"cross":[77],"sectional.":[78],"Sampel":[79],"dalam":[80,136],"didapat":[83],"melalui":[84],"metode":[85],"purposive":[86],"sampling":[87],"memenuhi":[91],"kriteria":[92],"inklusi.":[93],"Analisis":[94],"cara":[98],"menghitung":[99,108],"medik":[101,104],"non":[103,166],"langsung":[105,130],"diikuti":[106],"nilai":[109,145],"RUB":[110,146],"mengetahui":[112],"paling":[115,171,177],"cost":[116,182],"utility.":[117],"bulan":[122],"Agustus-September":[123],"Data":[125],"meliputi":[127],"total":[128],"transportasi.":[133],"Kualitas":[134,194],"diukur":[139],"kuesioner":[141],"DQOL.":[142],"Hasil":[143,160],"menunjukkan":[144,163],"Rp.":[148,155],"5.389.203;":[149],"?U":[150,157],"=":[151,158],"0,749":[152],"sedangkan":[153],"4.117.949;":[156],"0,754.":[159],"uji":[161],"sensitivitas":[162],"obat":[165],"ADO":[167],"memiliki":[168],"rentang":[169],"panjang":[172],"sehingga":[173],"menjadi":[174],"faktor":[175],"berpengaruh.":[178],"Penggunaan":[179],"glimepirid":[180],"lebih":[181],"utility":[183],"gliquidone.":[186],"Kata":[187],"kunci:":[188],"Antidiabetik":[189],"oral,":[190],"CUA,":[191],"Mellitus,":[193]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-02-03T00:00:00"}